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Biocatalysis has become a powerful tool for the synthesis of high-value compounds, particularly so in the
case of highly functionalized and/or stereoactive products. Nature has supplied thousands of enzymes
and assembled them into numerous metabolic pathways. Although these native pathways can be use to
produce natural bioproducts, there are many valuable and useful compounds that have no known natural
biochemical route. Consequently, there is a need for both unnatural metabolic pathways and novel enzymatic
activities upon which these pathways can be built. Here, we review the theoretical and experimental strate-
gies for engineering synthetic metabolic pathways at the protein and pathway scales, and highlight the chal-
lenges that this subfield of synthetic biology currently faces.Chemistry & BSynthetic Biology at the Protein Scale
Through natural evolution, organisms have acquired the capacity
tocatalyzeamultitudeofdiversechemical reactionsasameans to
proliferate in awide rangeof uniquemicroenvironments. Although
onlya small fractionof theearth’sbiodiversity (andanevensmaller
subset of its composite enzymes) has been characterized, the
identificationand isolationof novel proteinswithuniqueproperties
or enzymatic function is a laborious procedure. One particularly
promising source of new enzymes and enzymatic activities is
the emerging field of metagenomics (Handelsman, 2004). None-
theless, the physical and catalytic properties of natural enzymes
often render them as incompatible or, at the very least, unopti-
mized for use in engineered pathways and strains. In caseswhere
natural evolution has fallen short of industrial needs, the tools and
practices of synthetic biology can be applied to aid in the creation
of designer enzymes and cellular phenotypes. The challenge of
building new enzymes and reengineering natural ones has been
approachedwith the development of predictive theoretical frame-
works and a range of experimental techniques (Figure 2).
Theoretical Approaches
Computational tools exist to adapt the natural array of proteins
for use in an increasing number of applications. For example,
the effects of codon bias on expression levels (Kane, 1995; Gus-
tafsson et al., 2004) can be resolved by design tools such as
Gene Designer (Villalobos et al., 2006). Other effects such as
Shine-Dalgarno sequences, promoter strength, and mRNA
stability can be similarly optimized. Nonetheless, the application
of these tools is still limited to the biochemical diversity found in
nature. To increase the number and efficiency of biologically
catalyzed reactions, more sophisticated in silico techniques
are needed. Although full-scale protein folding and ab initio
protein design andmodeling are neither trivial nor currently prac-
tical, the use of solved protein structures, strong physical
models, and experimentally derived libraries allow for the design
and improvement of enzymes. These theoretically designed
proteins in turn have significant potential to impact pathway-
level synthetic metabolism (Yoshikuni et al., 2008).Introduction
Synthetic biology has emerged as a powerful discipline for the
creation of novel biological systems (Endy, 2005; Pleiss, 2006),
particularly within the subfield of metabolic pathway and product
engineering (Keasling,2008;Savageetal., 2008).Continuingefforts
to characterize and understand natural enzymes and pathways
haveopened thedoor for thebuildingof syntheticpathways toward
exciting and beneficial compounds such as the antimalarial drug
precursor artemisinic acid (Ro et al., 2006) and several branched-
chain alcohols for use as biofuels (Atsumi et al., 2008b). The need
for synthetic metabolic routes is a consequence of the fact that
the array of compounds of interest for biosynthesis vastly outnum-
bers the availability of characterized pathways and enzymes.
Several key building blocks can be made biologically (Patel et al.,
2006);however,a recent report fromtheU.S.DepartmentofEnergy
highlighted12biomass-derivedchemical targets, only half ofwhich
have known biochemical routes (Werpy and Petersen, 2004).
With the lack of characterized natural pathways to synthesize
many high-value compounds, we must learn to forge our own
metabolic routes toward these molecular targets. Logically, it
follows that for unnatural pathways, we will need new, unnatural
enzymes from which these pathways can be composed. The
parts-devices framework of synthetic biology lends itself well
to this dual-sided problem of synthetic pathway creation
(Endy, 2005); that is, pathways can be thought of as metabolic
devices composed of individual enzyme-catalyzed reaction
parts. Implicit within this framework is the idea that the chal-
lenges of pathway creation are best approached at both the
part and device levels. In this review, we first discuss efforts at
the protein-level for broadening the array of enzyme parts that
can be recruited for use in synthetic pathways. The discussion
is then expanded to pathway-level synthetic biology, where we
review the tools available for designing metabolic pathways
from enzyme-level parts and the implementation strategies for
realizing these pathways experimentally. The overall process of
pathway creation (Figure 1) combines experimental and theoret-
ical components of synthetic biology at both scales.iology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 277
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Creation
The creation process includes protein-level
recruitment and reengineering of enzymes and
pathway-level efforts to design and assemble
these enzymes into an unnatural pathway.278 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd Alwere well correlated with antibody binding affinity. Using this
relationship, they were able to generate an improved lysozyme
antibody design that demonstrated a 140-fold increase in
binding. Although neither of these examples fully describe
protein structure/function relationships, each does offer a unique
insight into the problem. Namely, they drastically reduced the
sequence space of potential modifications to a manageable
subset with a high probability of success. In this manner, such
empirical models serve as an important tool in the design and
improvement of enzymes.
Using a quantum transition state framework, great strides
have beenmade in the in silico development of enzyme activities
(Jiang et al., 2008; Rothlisberger et al., 2008; Kaplan and
DeGrado, 2004). At the heart of these efforts is a strong under-
standing of the desired catalytic mechanism and its associated
transition states and reaction intermediates. Once compiled,
this information can be used to generate an active site of the
appropriate dimensions with critical residues incorporated into
appropriate locations for catalysis. At this point, the designer
has two options: try to identify a suitable folded scaffold that
can accommodate the active site with minimal mutations or
generate a protein backbone with correctly folded active site
de novo. Each method has its inherent advantages and chal-
lenges. Although finding a host scaffold would appear to be
the simpler of the two, it requires extensive searches of protein
structure libraries with tools such as RosettaMatch (Zanghellini
et al., 2006). Nonetheless, this approach has had some success
with the catalysis of unnatural reactions such as the retro-aldol
catalysis of 4-hydroxy-4-(6-methoxy-2-naphthyl)-2-butanone
(Jiang et al., 2008) and the Kemp elimination (Rothlisberger
et al., 2008). Coupled with experimental techniques, in-silico-
designed enzymes can have activity levels comparable withAn empirical approach to synthetic protein design includes an
understanding of the protein sequence/function relationship.
One example is the use of a linguistic metaphor to describe
a protein sequence (Searls, 1997, 2002). In language, a sentence
is composed of a sequence of words whose parsed meaning is
a function of not only their individual definitions but also their
connotations, which are encoded by their type (part of speech)
and their relative location to other words. Similarly, a protein
‘‘sentence’’ is composed of residues that not only have a defini-
tive identity but also possess chemical properties and a relative
position that affect the subsequent fold and function of the resul-
tant protein (Przytycka et al., 2002). Building on the successes of
a putative protein grammar (Przytycka et al., 2002; Abe and Hir-
oshi, 1997), Loose et al. (2006) recently demonstrated its use in
the design of new antimicrobial peptides. Using the TEIRESIAS
algorithm (Rigoutsos and Floratos, 1998), a library with
homology to known sequences restricted to below 60% was
generated with approximately 50% of designs showing some
antimicrobial activity. An alternative approach to modeling
protein sequence/function relationships involves the use of
folded protein scaffolds and quantum transition state models.
Through detailed crystal structures and transition state models,
Hederos et al. (2004) noted that the active site of a glutathione
transferase was of the appropriate size and structure to stabilize
the transition state complex of the hydrolytic degradation of
a thioester. By introducing a histidine residue within the active
site they were able to impart significant thioesterase activity.
Finally, physics-based free energy approaches have been devel-
oped to predict protein structure/function relationships in the
context of antibody binding strength. Although total free energy
models were not a good predictor, Lippow et al. (2007) found
that the electrostatic interaction contributions to total energyFigure 2. Flowchart for the Creation of New
Enzymes with Experimental Techniques
and Computational Tools
New enzymes generated with these methods are
examined for desired properties and either further
reengineered or adapted for use in unnatural path-
ways.l rights reserved
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contrast, de novo protein scaffold development requires signifi-
cant computational effort to consider not only the stability of the
desired conformation of the backbone and active site but also
the likelihood of destabilization. Nonetheless, Kaplan and
DeGrado (2004) have successfully used such an approach to
generate an O2-dependent phenol oxidase. Despite the compu-
tational overhead associated with thesemethods, their feasibility
points to an improving and functional understanding of protein
structure/function relationships, leading to increased possibili-
ties for the rational design of enzymes and proteins.
In the absence of rational insight, theoretical tools can assist
experimental techniques in generating new and improved
proteins. One common technique is protein recombination or
in vitro shuffling, which combines the best traits of two or more
individual enzymes (Stemmer, 1994a, 1994b). However,
successful recombination is contingent on shuffling at domain
boundaries to ensure proper folding of each domain. The predic-
tive algorithm SCHEMA, developed by Voigt et al. (2002), was
designed to aid in the screening process of such chimeric
proteins. By analyzing the nature and number of the disruptions
of the intermolecular interactions, Voigt et al. were able to
generate a metric correlated with the probability of active b-lac-
tamase hybrids of TEM-1 and PSE-4 (2002). Subsequent studies
by Meyer et al. (2003) have confirmed this correlation and used
SCHEMA-guided recombination to derive functional and diverse
libraries of cytochrome P-450 s (Otey et al., 2004) and b-lacta-
mases (Meyer et al., 2006). Another available predictive algo-
rithm is FamClash (Saraf et al., 2004), which analyzes chimeras
for the conservation of charge, volume, and hydrophobicity at
a given residue. Generated sequence scores have been demon-
strated to be well correlated with the activities of hybrid dihydro-
folate reductases. Although experimental techniques are
important generators of diverse protein libraries, tools such as
FamClash, SCHEMA, and other related sequence analysis
programs enrich such chimeric libraries and vastly improve their
value in the development of new and improved proteins.
Currently, these tools are incapable of predicting hits a priori;
however, their importance in successful protein design should
not be underestimated.
Experimental Approaches
Rather than focusing on the prediction of protein structure and
function, experimental techniques allow the improvement or
modification of existing enzymes, in some instances creating
entirely new enzymes and enzyme activities. These techniques
include mutagenesis, enzyme engineering and evolution, and
gene synthesis technology, with each boasting its own distinct
advantages and inherent limitations (Bonomo et al., 2006; Alper
and Stephanopoulos, 2007). Collectively, they comprise
a powerful set of tools for the efficient generation of enzymes
with user-specified properties. Protein recombination, for
example, provides a means by which secondary structural
elements, from natural or evolved proteins, can be rationally
assembled in a modular fashion to integrate domains featuring
desired attributes (Otey et al., 2004).
The construction of synthetic pathways typically involves the
recruitment of genes from an array of sources to provide the
required enzymatic function and activity (Figure 1). However,
heterologously expressed proteins, particularly those originatingChemistry & Biofrom a source organism belonging to a different kingdom than
that of the expression host, often suffer from poor activity as
a result of dissimilarities in codon usage. In such cases, the use
of synthetic genes with codon optimized sequences has been
frequently employed to achieve sufficient levels of functional
expression. Synthesis of a codon optimized xylanase gene
from Thermomyces lanuginosus DSM 5826 led to a 10-fold
improvement in expression level in E. coli (Yin et al., 2008). Plant
genes are often found to be poorly expressed in E. coli (Martin
et al., 2001). Martin et al. (2003) synthesized a codon optimized
variant of amorpha-4,11-diene synthase from the Artemisia
annua to catalyze the conversion of farnesyl pyrophosphate to
amorphadiene, aprecursor used for theproductionof theantima-
larial drugartemisinin. As thecost associatedwith gene synthesis
continues to decrease, imaginable applications of synthetic
genes and artificial, designer proteins to include increased
elements of rational design become increasingly plausible.
The versatility of directed evolution for engineering desired
enzyme attributes is highlighted by a multitude of recent works
employing this approach for adiverseassortment of applications,
including theenhancement of thermal stability (Asakoet al., 2008;
Shi et al., 2008) and acid tolerance (Liu et al., 2008); promoting
higher chemo-, regio-, and enantio-selectivity toward substrates
(Asako et al., 2008); elimination of undesired biochemical activi-
ties (e.g., side reactions; Kelly et al., 2008); and improving heter-
ologous expression (Mueller-Cajar and Whitney, 2008). In the
example of the stereospecific reduction of 2,5-hexanedione to
(2S,5S)-hexanediol by alcohol dehydrogenase from the thermo-
philic bacteria Pyrcoccus furiosus, laboratory evolution was
used by Machielsen et al. (2008) to alter the enzyme’s optimum
temperature and improve its activity in recombinant E. coli under
moderate culture conditions. Meanwhile, Aharoni et al. (2004)
have achieved functional expression of mammalian paraoxo-
nases PON1 and PON3 in E. coli through a directed evolution
scheme that incorporated family DNA shuffling (shuffling of
DNA encoding homologous genes from different genetic sour-
ces) and randommutagenesis to achieve the first activemicrobial
expression of recombinant PON variants. As a tool, directed
evolution continues to benefit from refinements aimed at
improving the efficiency at which desired mutations can be ob-
tained from a minimal number of iterations while also reducing
screening efforts (Reetz andCarballeira, 2007;Reetz et al., 2008).
In addition to improving expression and altering the thermal
properties of heterologous enzymes, novel biochemical activi-
ties can be similarly engineered by the aforementioned strate-
gies. For example, cytochrome P450 BM3 fromBacillus megate-
rium has been engineered via directed evolution using several
sequential rounds of mutagenesis to alter its regioselectivity for
the hydroxylation of n-alkanes from subterminal positions to
that of the terminus (Meinhold et al., 2006). The approach has
been employed to convert several different n-alkanes to their
corresponding n-alcohols, including the hydroxylation of ethane
to ethanol as a means for producing more tractable transporta-
tion fuels from petrochemical feedstocks (Meinhold et al.,
2005). To promote high end-product specificity whilemaximizing
metabolite flux, the preferential activity of an enzyme between
multiple competing substrates can also be tailored. For instance,
the substrate specificity of pyruvate oxidase (PoxB) from E. coli
was altered via localized random mutagenesis to decrease itslogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 279
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olite, 2-oxo-butanoate (Chang and Cronan, 2000). Synthetic
pathways incorporating this PoxB mutant will accordingly
display preferential synthesis of products from the four-carbon
precursor. Meanwhile, Tsuge et al. (2003) utilized site-directed
mutagenesis to shift the substrate specificity of PhaJ, an
R-specific enoyl-coenzyme A (CoA) hydratase from Aeromonas
caviae from short-chain 3-hydroxyacyl-CoA precursors toward
those with longer carbon chain lengths (8 to 12). When incorpo-
rated into an engineered polyhydroxyalkanoate (PHA) synthesis
pathway in E. coli, increased molar fractions of C8 and C10 3-hy-
droxyacid monomer units were found to be incorporated into
PHA. In this case, the capacity to distinctly manipulate the
composition of PHAs makes possible the synthesis of novel bio-
plastics with customizable physical properties to meet commer-
cial requirements. The ability to finely tune the substrate speci-
ficity of an engineered enzyme is of particular importance for
promoting high selectivity and product yield, as well as for
reducing the ill-effects of molecular cross-talk between engi-
neered and endogenous pathways.
At the protein level, synthetic biology aims to expand the
catalog of well-characterized enzymes while also engineering
novel biochemistries. Subsequent incorporation of engineered
enzymes into synthetic pathways leads to the construction of
devices that can be implemented to achieve a user-specified
function, such as the production of biofuels or high-value phar-
maceutical compounds. The design and construction of new
metabolic routes from individual enzymes represents synthetic
biology at the next scale, the pathway scale, and has unique
challenges of its own.
Synthetic Biology at the Pathway Scale
Pathway-scale synthetic biology aims to create novel metabolic
routes toward both existing metabolites and unnatural
compounds. Traditionally, pathway engineering has been
synonymous with metabolic engineering and its toolbox has
been composed of the same tools: gene knockouts, flux optimi-
zation, gene overexpression, and the like. The ability to manipu-
late natural metabolism has seen many useful applications, such
as improving ethanol production in Saccharomyces cerevistiae
(Bro et al., 2006), solventogenesis in Clostridium acetobutylicum
(Mermelstein et al., 1993; Woods, 1995), and penicillin produc-
tion in Penicillium chrysogenum (Casqueiro et al., 2001). A key
limitation in all of these examples is the confinement of pathway
engineering to the manipulation of natural metabolism.
Continuing advances in characterizing, modifying, and even
creating enzymes (several of them discussed in the previous
section of this review) now allow us to build unnatural pathways
for the biological production of compounds. Understanding
synthetic biology at the protein scale affords us the opportunity
to apply it at the pathway scale.Chemistry & BioAs at the protein scale, pathway-level synthetic biology has
been approached from both theoretical and experimental fronts.
The theoretical work centers on the concept of pathway
design—assembling a logical series of enzyme-catalyzed reac-
tions to convert an accessible substrate into a valued final
compound. Theoretical pathway design probes what conver-
sions are possible and what enzyme parts need to be assembled
to create a functional metabolic device. In contrast, experimental
efforts focus on the construction and application of unnatural
pathways and serve as powerful real-world examples of what
these pathways can accomplish. Experimental approaches
enable the exploration of enzyme behaviors such as substrate
promiscuity and activity, both useful properties for creating
unnatural pathways that cannot readily be predicted with theo-
retical approaches.
Theoretical Approaches
Before an unnatural metabolic pathway can be built in the labo-
ratory, it must first be designed. The goal of pathway design is to
use a series of biochemically catalyzed reactions to connect
a target product molecule to either a cellular metabolite (such
as acetyl-CoA, a-ketoglutarate, or L-alanine) or to a feasible
feedstock (such as glucose or glycerol). This can be accom-
plished using either natural enzymes or engineered ones. The
sheer number of known enzymes (both natural and engineered)
and enzyme-catalyzed reactions available means that there will
almost certainly exist many possible theoretical pathways
toward a given target compound (Li et al., 2004; Hatzimanikatis
et al., 2005). Identifying and ranking these different possibilities
are the central challenges in pathway design.
One of the first steps in pathway design is obtaining knowledge
of the enzymes and enzyme-catalyzed reactions available for use
in a pathway. Comprehensive protein and metabolism data-
bases, such as BRENDA (Schomburg et al., 2004), KEGG (Kane-
hisa et al., 2006), Metacyc (Caspi et al., 2006), and Swiss-Prot
(Wu et al., 2006), provide a wealth of information on the pool of
natural, characterized enzymes that can be recruited. More
importantly, these databases reveal chemical conversions that
are achievable with enzymes. As of the preparation of this manu-
script, there are approximately 398,000 protein entries in Swiss-
Prot (build 56.2), fromwhich the enzymes are organized into 4757
four-digit enzyme classification (E.C.) groups in the most recent
version of BRENDA (build 2007.2). Because of the large number
of characterized enzymes, those performing similar reaction
chemistries are typically organized into generalized enzyme-
catalyzed reactions for the purposes of pathway construction
(Li et al., 2004). A generalized enzyme-catalyzed reaction is
defined as the conversion of one functional group or structural
pattern in a substrate into a different group or structure in its
product (Figure 3). Structural information about the nonreacting
portions of the substrate is ignored, making the identification of
enzymes to carry out a desired chemical conversion a muchFigure 3. Generalized Enzyme-CatalyzedReactions for a Subset of E.C. 1.1.1 Alcohol Dehydrogenases, E.C. 4.3.1 Ammonia-Lyases, and E.C.
2.5.1 Synthases
The ‘‘A’’ atoms present in the molecular structures are wildcards.
(A) Two different methods of assigning generalized reactions, one considering only the reacting parts of the molecule (core generalized reaction) and one iden-
tifying patterns of conserved molecular structure in addition to the reacting structural elements (conserved structure generalized reaction), arrive at the same
generalized reaction.
(B) The two methods arrive at different generalized reactions, illustrating the need for a generalization standard.
(C) A set of five enzymes within a three-digit E.C. class result in two different sets of generalized reactions, illustrating that the E.C. system does not necessarily
correlate with reaction generalization.logy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 281
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enzymes to a generalized reaction can be subjective (Figure 3).
One could for instance differentiate between reactions solely on
the reacting functional groups (i.e., aldehyde to alcohol) as Li
et al. (2004) did, or one could also include information about
conserved patterns of molecular structure between similar
enzyme-catalyzed reactions. Furthermore, generalized enzy-
matic reactions do not all fall cleanly into the existing E.C. system
(Figure 3C).
Despite the need for a universal standard in reaction general-
ization, several publically available tools utilize this approach to
address the problem of pathway design. The BNICE (Biochem-
ical Network Integrated Computational Explorer) framework
allows for the discovery of numerous possible metabolic routes
between two compounds (Li et al., 2004; Hatzimanikatis et al.,
2005). This framework was applied to aromatic amino acid
biosynthesis to find over 400,000 theoretical biochemical path-
ways between chorismate and phenylalanine, tyrosine, or trypto-
phan (Hatzimanikatis et al., 2005) and it was used to explore
thousands of novel linear polyketide structures (Gonza´lez-
Lergier et al., 2005). Our group has developed a database of
over 600 conserved structure generalized enzyme-catalyzed
reactions called ReBiT (Retro-Biosynthesis Tool, http://www.
retro-biosynthesis.com), which accepts as input a molecular or
functional group structure and returns as output all three-digit
E.C. groups capable of reacting with or producing that structure.
The University of Minnesota Biocatalysis/Biodegradation Data-
base (UM-BBD) uses a series of generalized reaction rules to
propose pathways step by step, with particular emphasis on
analyzing the degradation trajectories of xenobiotics (Ellis
et al., 2006; Fenner et al., 2008).
Typically multiple, and indeed in some cases, several thou-
sand, metabolic routes can be proposed for a given compound.
How does one distinguish logical, feasible pathways from frivo-
lous, improbable ones? What metrics can be applied to judge
one computationally generated pathway as superior (i.e., more
likely to be functionally constructed) to another? One way of nar-
rowing the choice of pathways is to apply natural precedent to
filter out unlikely pathway steps. In this strategy, a large set of
experimentally validated enzyme-catalyzed reactions are exam-
ined for patterns of structural change and a series of rules are
developed to give preference to reaction steps containing struc-
tural changes that follow these rules. This methodology is imple-
mented in the UM-BBD to avoid the ‘‘combinatorial explosion’’
that results when considering all the possible pathways that
any given compound can take (Fenner et al., 2008). Another
ranking strategy is to calculate the thermodynamic favorability
of the steps and to penalize pathways involving steps that are
energetically unfavorable. This approach is taken by the BNICE
framework (Hatzimanikatis et al., 2005) using a functional group
contribution method (Jankowski et al., 2008) to compute the
overall change in Gibbs energy for each individual pathway
step. A new pathway modeling tool, DESHARKY, quantifies
and employs metabolic burden as a metric for judging unnatural
pathways and, in particular, how they are connected to cellular
metabolism (Rodrigo et al., 2008). DESHARKY is a Monte-
Carlo-based algorithm that estimates the transcriptomic and
metabolic loads on cells expressing unnatural pathways and
calculates the decrease in specific growth rate as a result of282 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd Althese additional burdens. There are still other possibilities for
pathway ranking, such as the number of pathway steps taken,
the known substrate specificities (or lack thereof) of the enzymes
involved in each pathway, or the availability and diversity of
homologous enzymes to test at each pathway step. One of the
key challenges in pathway design is scoring pathways in a robust
and balanced manner, and only as more nonnatural pathways
are designed and built will there be a better understanding as
to which of these metrics are relevant and useful.
Experimental Approaches
With a target compound and a proposed metabolic route to
reach that compound in hand, one is now ready to begin exper-
imental implementation of that pathway. Synthetic pathway
construction occurs over several shades of novelty—from recre-
ating natural pathways in heterologous hosts to creating
synthetic pathways that parallel natural ones to building
completely novel metabolic routes toward unnatural compounds
from multiple, ordinarily unrelated enzymes (Figure 4). Here we
discuss the situations in which nonnatural pathways prove useful
and several general strategies for creating these pathways.
Through the course of evolution, nature has assembled many
pathways toward several useful compounds, such as the biofuel
and solvent 1-butanol in Clostridium acetobutylicum (Jones and
Woods, 1986; Du¨rre et al., 2002; Lee et al., 2008), the C5 terpe-
noid building block isopentenyl pyrophosphate in Saccharo-
myces cerevisiae (Seker et al., 2005), and the biopolymer polyhy-
droxybutyrate (PHB) in Ralstonia eutropha (Wang and Yu, 2007).
These pathways have physiological roles within their native
hosts; for example, the butanol pathway from acetyl-CoA in
C. acetobutylicum serves as an electron sink to regenerate
NAD+ for glycolysis while deacidifying its environment (Jones
and Woods, 1986). Pathways in nature are optimized through
evolution to accomplish their physiological objectives, yet in
most cases of pathway engineering, it is desired to maximize
the production of a target molecule in a pathway rather than to
accomplish a physiological goal. Butanol production inC. aceto-
butylicum, for instance, is constricted by cellular regulation tying
it to pH, redox conditions, and sporulation (Du¨rre et al., 2002; Lee
et al., 2008). The transference of natural pathways into heterolo-
gous hosts isolates these pathways from their regulatory
elements and represents a first small step toward the creation
of nonnatural metabolism. Although heterologous pathway
expression is limited to pathways found in nature, it nonetheless
has proven effective in enhancing product titers and/or deregu-
lating compound production for a wide array of products,
including the compounds in the examples above (Atsumi et al.,
2008b; Kang et al., 2008; Martin et al., 2003; Pitera et al., 2007).
The next level of novelty in synthetic pathway construction is
creating metabolic routes that parallel natural pathways, typi-
cally by capitalizing on enzymatic promiscuity or enzyme engi-
neering to operate natural or near-natural pathways on nonnat-
ural substrates. This pathway construction strategy allows for
the biosynthesis of truly unnatural compounds. Returning to
the PHB example, recombinant R. eutrophia have been shown
to incorporate sulfur-containing short- and medium-chain length
thioacids into polythioester copolymers (Ewering et al., 2002).
The synthesis of these completely unnatural polymers was
made possible by taking advantage of the relatively broad
substrate specificity of PHA synthases (Hazer and Steinbu¨chel,l rights reserved
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of different monomer units of various sizes (C3–C16) and substit-
uents have been incorporated into PHA copolymers (Steinbu¨chel
and Valentin, 1995). Another example of parallel pathway
construction is the synthesis of triacetic acid lactone from
acetyl-CoA by expressing an engineered fatty acid synthase B
from Brevibacterium ammoniagenes (Zha et al., 2004). This
multifunctional enzyme has many domains designed to catalyze
the various reductions and condensations necessary for fatty
acid synthesis (Meurer et al., 1992). By specifically inactivating
the ketoacyl-reductase domain of this fatty acid synthase, the
enzyme could no longer use NADPH to reduce its acetyl-CoA
condensation products, causing them to circularize into triacetic
acid lactone rather than forming linear fatty acids. Finally, natural
products can be synthesized by arranging whole or partial path-
ways to form a mixed, synthetic metabolic route. For example,
Figure 4. Strategies for Synthetic Pathway Creation Arranged in
Increasing Degrees of Departure from Nature
A, B, C, D, F, a, b, g, and D represent metabolites, E represents an enzyme
catalyzing a reaction, and 3 represents an engineered enzyme catalyzing
a reaction. In (1), a natural pathway in its native host is transferred to a heterol-
ogous host, decoupling it from native regulation. This strategy is limited to the
production of natural products using natural pathways. In (2), new pathways
are made in parallel to natural ones through the use of promiscuous enzymes
(2a), enzyme engineering (2b), or combinations of natural pathways (2c). Strat-
egies 2a and 2b allow for the synthesis of new, nonnatural products, whereas
2c allows for the creation of new metabolic routes between natural metabo-
lites. Strategy 3 represents de novo pathway construction, where individual
unrelated enzymes are recruited to form entirely unnatural pathways. This
can be done using native enzyme activities (3a), promiscuous enzymes (3b),
engineered enzymes (3c), or combinations thereof.Chemistry & Biothe theoretical yield of L-glutamate was improved from 1 mol
glutamate per mol glucose to 1.2 mol per mol by augmenting
the native Corynebacterium glutamicum pentose phosphate
pathway with a phosphoketolase from Bifidobacterium lactis
(Chinen et al., 2007). This strategy allowed for the production
of acetyl-CoA without the loss of carbon caused by pyruvate
decarboxylation to acetyl-CoA and resulted in increased gluta-
mate titers and productivity.
One of the most promising (and challenging) strategies for
building synthetic pathways is de novo pathway construction:
the creation of pathways using disparate enzymes to form
entirely unnatural metabolic routes toward valuable compounds.
This method of pathway building does not rely upon natural
precedent, but rather allows one to build entirely newmetabolite
conduits from individual enzymatic pieces. As a result, this
approach allows for the biosynthesis of the widest array of
compounds. However, this strategy is themost difficult to realize
given that for a completely unnatural pathway, theremight not be
a complete set of appropriate known enzymes in nature to build
it. De novo pathway construction illustrates the need for a more
complete set of enzymatic tools for use in building synthetic
pathways, and frequently this strategy is coupled with enzyme
engineering or the exploitation of enzymatic promiscuity to
compensate for the absence of a natural enzyme to execute
a desired conversion step.
Because of the challenge in creating functional de novo path-
ways, few examples exist. However, those that are available
describe the biosynthesis of a wide range of useful compounds
and illustrate the utility of the approach. For instance, a pathway
for the biosynthesis of 1,2,4-butanetriol from D-xylose and
L-arabinose was assembled using pentose dehydrogenases
and dehydratases from Pseudomonas fragi and E. coli and ben-
zoylformate decarboxylase fromPseudomonas putida (Niu et al.,
2003). In this case, multiple decarboxylases were screened to
find a promiscuous decarboxylase from P. putida capable of
acting on a 3-deoxy-glyceropentulosonic acid intermediate in
the pathway. Another example of exploiting substrate promis-
cuity in de novo pathway design is in the synthesis of several
higher biofuels such as 2-methyl-1-butanol, isobutanol, and
2-phenylethanol from glucose in E. coli (Atsumi et al., 2008b).
Here, several 2-keto-acid decarboxylases were screened to
identify one from Lactococcus lactis for use in creating alcohols
from 2-ketoacids (when combined with native E. coli alcohol
dehydrogenase activity). In a third example, a synthetic pathway
for the unnatural aminoacid phenylglycine from phenylpyruvate
was made by combining hydroxymandelate synthase, hydroxy-
mandelate oxidase, and D-(4-hydroxy)phneylglycine amino-
transferase activities from Amycolatopsis orientalis, Strepto-
myces coelicolor, and P. putida (Mu¨ller et al., 2006). Finally,
engineered enzymes can be employed to create de novo path-
ways, as in the recent case of the synthesis of 3-hydroxypro-
pionic acid from alanine in E. coli (Liao et al., 2007). Here, a lysine
2,3-aminomutase fromPorphyromonas gingivalis (Brazeau et al.,
2006) was evolved to have alanine 2,3-aminomutase activity, al-
lowing for the biosynthesis of b-alanine. Combining this evolved
enzyme with b-alanine aminotransferase and endogenous
alcohol dehydrogenase activities afforded the final 3-hydroxy-
propionic acid product. Another very recent work utilizes engi-
neered pyruvate decarboxylase and 2-isopropylmalate synthaselogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 283
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E. coli (Zhang et al., 2008). By engineering the enzymes respon-
sible for elongating 2-ketoacids and carrying out their decarbox-
ylation and reduction, the production of a broader array of
longer-chain alcohols was enabled.
Conclusions
The design and assembly of unnatural metabolic pathways
represents a young and exciting field with the potential to
supplement, expand upon, or even replace current industrial
processes for the production of fine and commodity chemicals.
Synthetic pathway engineering integrates many components
and consequently is highly interdisciplinary (Figure 1). Key issues
that need to be overcome in pathway design are (1) establishing
a standard for generalized enzyme-catalyzed reactions, (2)
capturing enzyme substrate preferences in these generalized
reactions, and (3) determining the pathwaymetrics that correlate
with successful pathway construction. Overcoming the first two
challenges will allow for the creation of the next generation of
pathway design tools that better account for enzyme behavior,
whereas conquering the last challenge will afford us the ability
to rank and choose metabolic pathways and refine the results
from design tools. For experimentally implementing unnatural
pathways, the central challenge is the limited number of charac-
terized enzymes for the construction of new pathways. In partic-
ular, there is great demand for both promiscuous natural
enzymes and engineered enzymes to perform specific desired
reactions.
The need for new enzymes has given rise to several theoretical
frameworks for relating protein sequence, structure, and func-
tion. These frameworks each address a piece of the problem—
energetics, active site catalysis, and protein backbone structure,
etc.—but the ability to routinely build whole enzymes is still in the
distant future. In the meantime, mimicking active sites, back-
bones, and protein linguistics from nature has proven fruitful in
creating novel proteins. Experimental evolution and chimeragen-
esis of enzymes are standard ways of imparting unnatural prop-
erties, particularly in the absence of detailed information about
the protein. The power of these experimental techniques is
primarily limited by the size of the resulting enzyme libraries
and the throughput of the screen to analyze them. Computa-
tional tools such as SCHEMA (Voigt et al., 2002) and Famclash
(Saraf et al., 2004) can assist in focusing and enriching these
libraries.
Because biotechnology is increasingly relied upon as a means
for chemical production, progress on the creation of new
enzymes and unnatural pathway design and construction will
flourish. These new pathways must still be expressed within
a cellular context, thus improving and understanding unnatural
pathway efficacy at a systems level will be important for shatter-
ing barriers in pathway expression and product titer. For
example, application of flux balance analysis (Edwards et al.,
2002) can guide systems-level integration of nonnatural path-
ways with host metabolism. Furthermore, redox balancing and
cofactor regeneration with respect to new pathways are critical
to minimize their burden on the host cell (Endo and Koizumi,
2001). Systems-level functionality can also be coupled with
unnatural pathways, for instance in the delivery of recombinant
microbes to a cancerous tumor (Anderson et al., 2006). Such284 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd Allmicrobes could be engineered to simultaneously produce and
deliver a drug. Established and recent advances in metabolic
engineering, such as global transcription machinery engineering
(Alper and Stephanopoulos, 2007), can complement synthetic
biology in this regard, leading to improved performance of novel
pathways.
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